<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03305562</url>
  </required_header>
  <id_info>
    <org_study_id>00046620</org_study_id>
    <nct_id>NCT03305562</nct_id>
  </id_info>
  <brief_title>Pediatric Hypertension Registry (PHREG)</brief_title>
  <acronym>PHREG</acronym>
  <official_title>Pediatric Hypertension Registry (PHREG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric hypertension is increasingly common and is a precursor for adult cardiovascular and
      renal disease. But even during childhood, hypertension is associated with significant
      morbidity, including cognitive impairment and organ damage. However, the cause of pediatric
      hypertension, the response to treatment, and the mechanisms behind organ damage are
      incompletely understood. Due to these limitations, there are no first-line medications, and
      treatment is often inadequate. An improved comprehension of the course of pediatric
      hypertension could enhance clinical care. The goal of this proposal is to create a registry
      of patients with hypertension to better enable research into this important disease. This
      patient registry will enhance the investigators ability to quickly collect and analyze data
      for research studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will include all subjects evaluated at the Brenner Children's Hospital
      Pediatric Nephrology clinic since January 1st, 2013 with a diagnosis of high blood pressure
      confirmed with three separate blood pressure measurements &gt;=90th percentile for age, sex, and
      height, or &gt;120/80 mmHg. The investigators will exclude patients whose initial evaluation
      occurred on or after their 18th birthday.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 20, 2017</start_date>
  <completion_date type="Anticipated">October 20, 2027</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>10 years</time_frame>
    <description>Auscultated blood pressure measurements in clinic</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular hypertrophy</measure>
    <time_frame>10 years</time_frame>
    <description>Left ventricular hypertrophy and other cardiac structural/function changes on echocardiograms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Albuminuria</measure>
    <time_frame>10 years</time_frame>
    <description>Urinary albumin-to-creatinine (&gt;30 mg/g)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ambulatory blood pressure</measure>
    <time_frame>10 years</time_frame>
    <description>Ambulatory blood pressure monitoring data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function</measure>
    <time_frame>10 years</time_frame>
    <description>Glomerular filtration rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uric acid</measure>
    <time_frame>10 years</time_frame>
    <description>Serum uric acid</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Hypertension</condition>
  <condition>Pediatric Disorder</condition>
  <arm_group>
    <arm_group_label>Retrospective cohort</arm_group_label>
    <description>The cohort of patients seen prior to the implementation of a standardized clinical management protocol on 10/01/2017 whose data is collected retrospectively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective cohort</arm_group_label>
    <description>The cohort of patients seen initially seen after implementation of a standardized clinical management protocol on 10/01/2017 whose data is collected prospectively.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects that are patients in the Brenner Children's Hospital Pediatric Nephrology Clinic
        with a confirmed diagnosis of high blood pressure.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients at the Wake Forest Baptist Health Brenner Children's Hospital Pediatric
             Nephrology clinic

          -  Diagnosis of hypertension confirmed with three separate blood pressure measurements

          -  Diagnosis after January 2013

          -  &gt;90th percentile for age, sex, height, or &gt;120/80.

        Exclusion Criteria:

        - Patients whose initial evaluation occurred on or after their 18th birthday.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew M South, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007 Sep 25;116(13):1488-96. Epub 2007 Sep 10.</citation>
    <PMID>17846287</PMID>
  </reference>
  <reference>
    <citation>Richey PA, Disessa TG, Somes GW, Alpert BS, Jones DP. Left ventricular geometry in children and adolescents with primary hypertension. Am J Hypertens. 2010 Jan;23(1):24-9. doi: 10.1038/ajh.2009.164. Epub 2009 Oct 22.</citation>
    <PMID>19851297</PMID>
  </reference>
  <reference>
    <citation>King JT Jr, DiLuna ML, Cicchetti DV, Tsevat J, Roberts MS. Cognitive functioning in patients with cerebral aneurysms measured with the mini mental state examination and the telephone interview for cognitive status. Neurosurgery. 2006 Oct;59(4):803-10; discussion 810-1.</citation>
    <PMID>17038944</PMID>
  </reference>
  <reference>
    <citation>Washburn LK, Nixon PA, Russell GB, Snively BM, O'Shea TM. Preterm Birth Is Associated with Higher Uric Acid Levels in Adolescents. J Pediatr. 2015 Jul;167(1):76-80. doi: 10.1016/j.jpeds.2015.03.043. Epub 2015 Apr 11.</citation>
    <PMID>25868431</PMID>
  </reference>
  <reference>
    <citation>Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008 Aug 27;300(8):924-32. doi: 10.1001/jama.300.8.924.</citation>
    <PMID>18728266</PMID>
  </reference>
  <reference>
    <citation>Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001 Nov;38(5):1101-6.</citation>
    <PMID>11711505</PMID>
  </reference>
  <reference>
    <citation>Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002 May;(246):1-190.</citation>
    <PMID>12043359</PMID>
  </reference>
  <reference>
    <citation>Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987 Jun;34(3):571-90.</citation>
    <PMID>3588043</PMID>
  </reference>
  <reference>
    <citation>Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, Zachariah JP, Urbina EM; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014 May;63(5):1116-35. doi: 10.1161/HYP.0000000000000007. Epub 2014 Mar 3.</citation>
    <PMID>24591341</PMID>
  </reference>
  <reference>
    <citation>Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009 Jun;22(6):709-14. doi: 10.1016/j.echo.2009.03.003. Epub 2009 May 7.</citation>
    <PMID>19423289</PMID>
  </reference>
  <reference>
    <citation>Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009 May;18(3):246-51. doi: 10.1097/MNH.0b013e3283294b98. Review.</citation>
    <PMID>19276802</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2017</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

